rtility and fertility preservation. We will review the reproductive risks of cancer therapies, and the various options to help survivors build a family after treatment with fertility altering therapies. Presentations will cover current and updated guidelines in male and female cancer survivors as well as the most current strategies for non-oncologic fertility preservation.